AVROBIO, Inc. (AVRO) Financials
AVRO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 101.1 million | 6.4 million |
2023-09-30 | 110.5 million | 7.7 million |
2023-06-30 | 133.8 million | 11.8 million |
2023-03-31 | 83.0 million | 30.0 million |
AVRO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -8.0 million | 607000 |
2023-09-30 | -20.2 million | 2.2 million |
2023-06-30 | -14.7 million | 1.5 million |
2023-03-31 | -20.3 million | 2.5 million |
AVRO Net Income
No data available :(
AVRO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 98.3 million | - | 878000 |
2023-09-30 | 105.8 million | - | 1.8 million |
2023-06-30 | 124.7 million | - | 2.4 million |
2023-03-31 | 72.3 million | 15.4 million | 3.0 million |
AVRO Shares Outstanding
AVRO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 4.4 million | 5.2 million | - |
2023-09-30 | - | 14.8 million | 6.3 million | - |
2023-06-30 | - | 11.1 million | 4.6 million | - |
2023-03-31 | 8000 | 17.3 million | 7.9 million | - |
AVRO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | - |
2023-06-30 | - | 879000 |
2023-03-31 | - | 920000 |
AVRO
Price: $1.22
52 week price:
Earnings Per Share: 0.27 USD
P/E Ratio: -13.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 362600
Market Capitalization: 58.8 million